Top Liver Diseases Treatment Stocks and ETFs to Buy
Liver Diseases Treatment Stocks and ETFs Ranked by Danelfin AI
Filter stocks:
Alpha Signals:
Rank | Company | Country | AI Score | Change | Fundamental | Technical | Sentiment | Low Risk | Perf YTD | Industry / Focus | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Rank | Company | Country | AI Score | Change | Fundamental | Technical | Sentiment | Low Risk | Perf YTD | Industry / Focus | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Rank | Company | Country | AI Score | Change | Fundamental | Technical | Sentiment | Low Risk | Perf YTD |
|---|
Showing 1 to 16 of 16 stocks
Industry / Focus |
|---|
1 | ALGSAligos Therapeutics Inc |  | 0 | -39.80% | |||||||
2 | MIRMMirum Pharmaceuticals Inc | | |||||||||
3 | SGMTSagimet Biosciences Inc | | |||||||||
4 | BLTEBelite Bio Inc | | |||||||||
5 | MLYSMineralys Therapeutics Inc | | |||||||||
6 | | ||||||||||
7 | | ||||||||||
8 | | ||||||||||
9 | | ||||||||||
10 | | ||||||||||
11 | | ||||||||||
12 |  | ||||||||||
13 |  | ||||||||||
14 | | ||||||||||
15 | | ||||||||||
16 | |
59.03% |
28.88% |
-8.31% |
-23.64% |
-9.30% |
29.08% |
-32.52% |
69.82% |
30.89% |
8.89% |
-25.62% |
-23.86% |
4.63% |
-5.15% |
-46.90% |